Leveraging AI Chatbots for Personalized Content Delivery: An Empirical Study in the Pharmaceutical Industry

Abstract:

This empirical study examines the strategic incorporation of AI-driven chatbots in the pharmaceutical sector for tailored content distribution, improved user engagement, and data-driven decision-making. The digital revolution is reshaping pharmaceutical marketing, with AI chatbots providing a scalable, round-the-clock solution for engaging patients, healthcare professionals, and consumers while ensuring compliance within a regulated framework. A quantitative methodology was employed to gather data from 120 participants within the Indian pharmaceutical industry. Findings from reliability analysis, factor analysis, chi-square tests, and multiple regressions indicated that customised chatbot content greatly affects user engagement, brand trust, customer loyalty, and data-driven decision-making. The research verifies that machine learning algorithms in AI chatbots can adaptively customise responses according to user behaviour and preferences, enhancing brand relationships and informing marketing plans. Additionally, chatbots function as essential data collection instruments that facilitate market intelligence, campaign optimisation, and regulatory communication. Managerial implications underscore the necessity for ethical supervision, interdepartmental cooperation, and ongoing content modification. This study addresses a significant gap by offering empirical evidence regarding the efficacy of AI chatbots in pharmaceutical marketing, a field historically dependent on in-person interactions. Research indicates that the integration of chatbots into an omnichannel strategy improves customer experience, lowers communication expenses, and facilitates agile, compliant digital marketing. The study provides strategic recommendations for pharmaceutical companies seeking to utilise AI chatbots as competitive advantages in the changing digital environment.